Anheuser-Busch InBev (NYSE:BUD) stock has fallen by 11% over the past three months as a poor earnings report released back in October sent the stock over a bit of a cliff. While it has started to bounce back, at $83, it’s still about $10 away from where it was before the drop.
The good news is that the stock could be a great deal today for dividend investors. With its dividend yield now up to 2.4%, investors get a chance to secure a better return from the stock than before it declined.
Although the company is struggling to find ways to grow, it’s a fairly decent value buy, trading at 18 times earnings and only 2.3 times book value. That’s not much of a premium for a company that has a strong portfolio of drinks and that still generated $4.4 billion in profit in 2018.
And it’s on track for a strong finish to 2019 as in each of the past three quarters its net income has come in at $2.5 billion or better.
However, the company could still generate growth from one unlikely area: cannabis. The company’s subsidiary, Labbatt, has been working with marijuana producer Tilray (NASDAQ:TLRY) in an effort to research cannabis-infused beverages for the cannabis market in Canada, which is now open to edible products, including beverages.
While it’s still in the early stages, this could be an area that helps give Anheuser an exciting new product that could potentially find its way in the U.S. market, whenever marijuana is legalized there.
